Inositol phosphoglycans in diabetes and obesity: Urinary levels of IPG A-type and IPG P-type, and relationship to pathophysiological changes

Molecular Genetics and Metabolism

Volumn 68, Issue 4, 1999, Pages 488-502

  Kunjara, Sirilaksana ^a   Wang, Dennis Y ^a   Greenbaum, A Leslie ^a   McLean, Patricia ^a   Kurtz, Anthony ^a   Rademacher, Thomas W ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Blood pressure; Diabetes; HbA1; Inositol phosphoglycans; Lipogenesis; Obesity; Pyruvate dehydrogenase; Syndrome X

Indexed keywords

HEMOGLOBIN A1C; INSULIN; PHOSPHATIDYLINOSITIDE; PYRUVATE DEHYDROGENASE COMPLEX; PYRUVATE DEHYDROGENASE PHOSPHATASE;

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES CONTROL; DIABETIC OBESITY; DISEASE ASSOCIATION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GLUCOSE OXIDATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; ISOMER; LIPID STORAGE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PHOSPHOINOSITIDE METABOLISM; PRIORITY JOURNAL; SYNDROME X; SYSTOLIC BLOOD PRESSURE; URINE LEVEL;

EID: 0033372658     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1006/mgme.1999.2936     Document Type: Article

References (53)

1. Himsworth HP. Diabetes mellitus: Its differentiation into insulin-sensitive and insulin insensitive types. Lancet 1:127-130, 1936.
2. Bennett PH, Bogardus C, Tuomilehto J, Zimmet P. Epidemiology and natural history of NIDDM: Non-obese and obese. In International Textbook of Diabetes Mellitus (Alberti KGMM, DeFronzo RA, Keen H, Zimmet P, Eds.). New York: Wiley, pp 147-169, 1992.
3. DeFronzo RA. The triumvirate: Beta cell, muscle, liver: a collusion responsible for NIDDM. Diabetes 37:667-687, 1988.
4. DeFronzo RA, Bonadonna RC, Ferrannini E. Pathogenesis of NIDDM. A balanced overview. Diabetes Care 15:318-368, 1992.
5. Reaven GM. Banting Lecture. Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988.
6. Reaven GM. Pathophysiology of insulin resistance in human disease. Physiol Rev 75:473-486, 1995.
7. Walker M. Obesity, insulin resistance, and its link to non-insulin-dependent diabetes mellitus. Metabolism 44 (Suppl 3):18-20, 1995.
8. Williams B. Insulin resistance: The shape of things to come. Lancet 344:521-524, 1994.
9. Larner J, Huang LC, Tang G, Suzuki S, Schwartz CFW, Romero G, Roulidis Z, Zeller K, Shen TW, Oswald AS, Lutterell L. Insulin mediators: Structure and formation. Cold Spring Harbor Symp 53:965-971, 1988.
10. Romero G, Lamer J. Insulin mediators and the mechanism of insulin action. Adv Pharmacol 24:21-50, 1993.
11. Romero G. Inositol glycans and cellular signalling. Cell Biol Int Rep 15:827-852, 1991.
12. Rademacher TW, Caro HN, Kunjara S, Wang DY, Greenbaum AL, McLean P. Inositolphosphoglycan second messengers. Brazil J Med Biol 27:327-341, 1994.
13. Varela-Nieto I, León Y, Caro HN. Cell signalling by inositol phosphoglycans from different species. Comp Biochem Physiol 115B:223-241, 1996.
14. Kunjara S, Caro HN, McLean P, Rademacher TW. Tissue specific release of inositol phosphoglycans. In Biopolymers and Bioproducts: Structure, Function and Applications (Svasti J, et al. Eds.). Bangkok, Thailand: Samakkhisan (Dokya), pp 301-306, 1995.
15. Caro HN, Kunjara S, Rademacher TW, León Y, Jones DR, Avila MA, Varela-Nieto I. Isolation and partial characterisation of insulin-mimetic inositol phosphoglycans from human liver. Biochem Molec Med 61:214-228, 1997.
16. Romero G, Gamez G, Huang LC, Lilley K, Lutterell L. Antiinositolglycan antibodies selectively block some of the actions of insulin in intact BC3H1 cells. Proc Natl Acad Sci USA 87:1476-1480, 1990.
17. Varese RV, Standaert MC, Yamada K, Huang C, Zhang C, Cooper DR, Wang Z, Yang Y, Suzuki S, Toyota T, Lamer J. Insulin-induced activation of glycerol 3-phosphate acyltransferase by chiro-inositol-containing insulin mediator is defective in adipocytes of insulin resistant, type II diabetic Goto-Kakizaki rats. Proc Natl Acad Sci USA 91:11040-11044, 1994.
18. Lazar DF, Knez JJ, Medoff ME, Cuatracasas P, Saltiel AP. Stimulation of glycogen synthesis by insulin in human erythroleukemia cells requires the synthesis of glycosyl-phosphatidylinositol. Proc Natl Acad Sci USA 91:9665-9669, 1994.
19. Misek DE, Saltiel AR. An inositol phosphate glycan derived from a Trypanosoma brucei glycosyl phosphatidylinositol promotes protein dephosphorylation in rat epididymal adipocytes. Endocrinology 135:1869-1876, 1994.
20. Sanchez-Arias JA, Sanchez-Gutierrez JC, Guadano A, Alvarez JF, Samper B, Mato JM, Feliu JE. Impairment of glycosyl-phosphatidylinositol-dependent insulin signaling system in isolated rat hepatocytes by streptozotocin-induced diabetes. Endocrinology 131:1727-1733, 1992.
21. Villar-Palasi C, Farese RV. Impaired skeletal muscle glycogen synthase activation by insulin in the Goto-Kakizaki (G/K) rat. Diabetologia 37:885-888, 1994.
22. Kennington AS, Hill CH, Craig J, Bogardus C, Raz I, Ortmeyer HK, Hansen BC, Romero G, Lamer J. Low urinary chiro-inositol excretion in non-insulin dependent diabetes mellitus. N Engl J Med 323:373-378, 1990.
23. Suzuki S, Tanada Y, Hirai S, Abe S, Sosaki A, Suzuki K, Toyota T. Molecular mechanisms of insulin resistance in spontaneous diabetic G.K. (Goto-Kakizaki) rats. In New Directions in Research and Clinical Works for Obesity and Diabetes mellitus (Sakamoto N, Angel A, Hotta N, Eds.). Amsterdam: Elsevier, pp 197-203, 1991.
24. Ortmeyer HK, Bodkin NL, Lilley K, Lamer J, Hansen BC. Chiro-inositol deficiency and insulin resistance in spontaneously diabetic Rhesus monkeys. Endocrinology 132,640-645, 1993.
25. Asplin I, Galasko G, Larner J. Chiro-Inositol deficiency and insulin resistance: A comparison of the chiro-inositol- and the myo-inositol-containing insulin mediators isolated from urine, hemodialysate, and muscle of control and type II diabetic subjects. Proc Natl Acad Sci USA 90:5924-5928, 1993.
26. Suzuki S, Kawasaki H, Satoh Y, Ohtomo M, Hirai M, Hirai A, Hirai S, Onoda M, Matsumoto M, Hinokio Y, Akai H, Craig J, Larner J, Toyota T. Urinary chiroinositol excretion as an index marker of insulin sensitivity in Japanese type II diabetes. Diabetes Care 17:1463-1468, 1994.
27. Ostlund RE, McGill JB, Herskowitz I, Kipnis DM, Santiago JV, Sherman WR. D-chiro-inositol metabolism in diabetes mellitus. Proc Natl Acad Sci USA 90:9988-9992, 1993.
28. Prochazka M, Mochizuki H, Baier LJ, Cohen PTW, Bogardus C. Molecular and linkage analysis of type-1 protein phosphatase catalytic b subunit gene: Lack of evidence for its major role in insulin resistance in Pima Indians. Diabetologia 38:461-466, 1995.
29. Lilley K, Zhang CL, Villar-Palasi C, Larner J, Huang L. Insulin mediator stimulation of pyruvate dehydrogenase phosphatase. Arch Biochem Biophys 296:170-174, 1992.
30. Larner J, Huang LC, Suzuki S, Tang E, Zhang C, Schwartz CFW, Romero G, Luttrell L, Kennington AS. Insulin mediators and the control of pyruvate dehydrogenase complex. Ann NY Acad Sci 573:297-305, 1989.
31. Rodbell M. Metabolism of isolated fat cells. J Biol Chem 239:375-380, 1964.
32. Newman JD, Armstrong J McD, Bornstein J. Assay of insulin mediator activity with soluble pyruvate dehydrogenase phosphatase. Endocrinology 116:1912-1919, 1985.
33. Craig JW, Larner J, Asplin CM. Chiroinositol deficiency and insulin resistance. In Molecular Biology of Diabetes, Part II (Draznin B, LeRoith D, Eds.). Totowa, NJ: Humana Press, 1994.
34. Serrano J, Mateo CM, Caro JF. Insulin resistance: Cellular and molecular mechanisms. Recent Adv Endocrinol Metab 4:167-183, 1992.
35. Moller DE, Flier JS. Insulin resistance - Mechanisms, syndrome, and implications. N Engl J Med 325:938-948, 1991.
36. Kahn CR. Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes 43:1066-1084, 1994.
37. Krentz J, Nattrass M. Insulin resistance: A multifaceted metabolic syndrome. Insights gained using a low-dose insulin infusion technique. Diabetic Med 13:30-39, 1996.
38. Snedecor GW. Statistical Methods, 5th ed. Ames, IA: Iowa State Univ Press, 1964.
39. Ferrannini E. Physiological and metabolic consequences of obesity. Metabolism 44 (Suppl 3):15-17, 1995.
40. DeFronzo RA, Goodman AN, and The Multicenter metformin Study Group, Efficacy of metformin in patients with non-insulin dependent diabetes mellitus. N Engl J Med 333:541-549, 1995.
41. United Kingdom Prospective Diabetes Study (UKPDS). 13. Relative efficacy of randomly allocated diet, sulphonylurea, insulin or metformin in patients with newly diagnosed diabetes followed for three years. Br Med J 310:83-88, 1995.
42. Huang B, Gudi R, Wu P, Harris RA, Hamilton J, Popov KM. Isoenzymes of pyruvate dehydrogenase phosphatase. DNA-derived amino acid sequences, expression and regulation. J Biol Chem 273:17680-17688, 1998.
43. Galasko GTF, Bao Y, Broomfield J, Hooper NM, Turner AJ, Lamer J. Circulating factors and insulin resistance. 1. A novel myo-inositol 1,2-cyclic phosphate phosphoglycan insulin antagonist from human plasma is elevated in non-insulin-dependent diabetes mellitus. J Clin Endocrinol Med 80: 2419-2429, 1995.
44. Fonteles MC, Huang LC, Lamer J. Infusion of pH 2.0 D-chiro-inositol glycan insulin putative mediator normalizes plasma glucose in streptozotocin diabetic rats at a dose equivalent to insulin without inducing hypoglycaemia. Diabetologia 39:731-734, 1996.
45. Maret W, Jacob C, Vallee BL, Fischer EH. Inhibitory sites in enzymes: Zinc removal and reactivation by thionein. Proc Natl Acad Sci USA 96:1936-1940, 1999.
46. Reaven G, Lithell H. Landsberg L. Hypertension and associated metabolic abnormalities - The role of insulin resistance and the sympathoadrenal system. N Engl J Med 334: 374-381, 1996.
47. Machicao F, Mushack J, Seffer E, Ermel B. Haring HU. Mannose, glucosamine and inositol monophosphate inhibit the effects of insulin on lipogenesis. Further evidence for a role for inositol oligosaccharides in insulin action. Biochem J 266:909-916, 1990.
48. Martiny L, Antonicelli F, Thuillez B, Lambert B, Jacquemin C, Haye B. Control by thyrotropin of the production by thyroid cells of an inositol phosphate-glycan. Cell Signal 2:21-27, 1990.
49. Brautigan DL. Protein phosphatases. Recent Prog Hormone Res 49:197-214, 1994.
50. Panzram G. Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 30:123-131, 1987.
51. Baron AD. The coupling of glucose metabolism and perfusion in human skeletal muscle. The potential role of endothelium-derived nitric oxide. Diabetes 45(Suppl 1):S105-S109, 1996.
52. Alberti KGMM, Press CM. The Biochemistry of the Complications of Diabetes Mellitus (Keen H, Jarret J, Eds.). London: Edward Arnold, 1982.
53. Kubota M, Yamasaki Y, Sekiya M, Kubota M, Morishima T, Kishimoto R, Shichiri M, Kamada T. Portal insulin delivery is superior to peripheral delivery in handling of portally delivered glucose. Metabolism 45:150-154, 1996.